Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.
Clin Exp Dermatol
; 46(7): 1334-1335, 2021 Oct.
Article
in En
| MEDLINE
| ID: mdl-33864281
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
/
CARD Signaling Adaptor Proteins
/
Interleukin-4 Receptor alpha Subunit
/
Antibodies, Monoclonal, Humanized
/
Guanylate Cyclase
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Exp Dermatol
Year:
2021
Type:
Article
Affiliation country:
France